Imaging approaches to optimize molecular therapies.

Area of Science:

• Biomedical Imaging
• Molecular Therapy Development
• Oncology

Background:

• Molecular imaging is crucial for drug development, clinical trials, and therapy monitoring.
• Numerous new imaging technologies and targeted tracers exist for cancer, but implementation is uneven.
• Many imaging innovations lack validation for widespread use in drug development or clinical trials.

Purpose of the Study:

• To examine opportunities and challenges of using imaging biomarkers for molecular therapy development.
• To explore how imaging biomarkers can accelerate clinical trial design.
• To discuss the future integration of advanced imaging techniques for personalized cancer treatment.

Main Methods:

• Review of current imaging technologies and targeted tracers in cancer research.
• Analysis of challenges in the implementation and validation of imaging innovations.
• Examination of terminology issues related to quantitative imaging biomarkers.

Main Results:

• Despite technological advancements, uneven distribution and implementation of imaging technologies persist.
• Lack of validation and inconsistent terminology impede the development and use of imaging biomarkers.
• Opportunities exist to leverage imaging for improved molecular therapy development and clinical trial efficiency.

Conclusions:

• Integrating in vivo molecular imaging with image-guided biopsies and liquid biopsies will enhance cancer patient monitoring.
• Personalized treatment plans can be optimized through a combination of advanced imaging and molecular analyses.
• Overcoming current challenges is key to realizing the full potential of molecular imaging in oncology.